Characteristics of m<sup>6</sup>A-related LncRNAs in breast cancer as prognostic biomarkers and immunotherapy.

J Cancer · 2023 · PMC10539557 · PMID 37781080

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

We speculate that there may be significant differences in immune checkpoint, T cell, and APC cell inhibition between the high-risk and low-risk groups, which makes patients in the low-risk group unsuitable for immunotherapy.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.